MARSTACIMAB

UNII: 0UB3OA67O7
Preferred Substance Name: MARSTACIMAB

1985638-39-8
IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR (TFPI, EXTRINSIC PATHWAY INHIBITOR, EPI, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, LACI))
MARSTACIMAB [INN]
MARSTACIMAB [USAN]
PF-06741086

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

MARSTACIMAB

Synonyms and Mappings

Resources

Note